An expert says that a treatment for Covid-19 that is being worked on by a company in which Novak Djokovic holds a majority stake is similar to the principles of homeopathy.
The world No 1 men's tennis player was forced to leave Australia on Sunday after the country's immigration minister canceled his visa on the basis that he is a "talisman of anti-vaccination sentiment".
On Wednesday, it was revealed that the tennis player had acquired an 80% stake in the company that designs treatments for viral diseases and resistantbacteria.
The Resonant Recognition Model is a biophysical model based on findings that certain periodicities/frequencies within the distribution of energies of free electrons along theProtein are critical forProtein biological function and interaction withProtein receptors and other targets
If you want to understand the universe, think of energy, frequency and vibration, says the quote from the Serbian-American scientist.
The approach described on the website was similar to the method of treatment known as homeopathy, which claims that certain substances can be used in small amounts to treat illness.
Homeopaths claim that by mixing these substances in water or alcohol, they can create a mixture that can cause a healing response in the body.
He said it was a stretch for the company to call itself a biotech company. The innovative technology they describe on their website does not reflect current understanding of how biochemistry works. My fees are reasonable, if any athletes or other potential investors would like advice on not blowing their cash on this stuff.
The website says the company will soon start testing different treatment approaches, but a link to learn more appeared to be broken when the Guardian tried to access it. There was an announcement in July 2020 that the Covid-19 deactivation mechanisms would be tested.
Prof Peter Collignon, an infectious diseases physician and antimicrobial resistance expert, said the website used "fancy terms" without providing any evidence of success. He said that they had given nothing in the way of data. The website describes a way of finding a new molecule without providing any evidence of success.
Ivan Loncarevic, the CEO of the company, denied that the methods developed by his company had anything to do with homeopathy, and 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780 800-313-5780
He said in an interview that what they do has nothing to do with homeopathy. Homeopaths believe that you can transfer information from a chemical to water. We develop peptides with specific functions. Classical science is what this is.
We don't put our data on our website for everyone to see. We will publish an article in a scientific journal that will collect all our clinical testing.
Loncarevic said that the article would be published in two to three months after peer review.
Loncarevic said that they are innovative and that it was a stretch for them to call themselves a biotech company and that the technology described on their website did not reflect modern understanding of how biochemistry works.
He said that other pioneers in engineering or science, such as Galileo, had faced similar criticism. He said this was the first time he had heard of the problem and that it was not done on purpose.
Philip Oltermann is in Berlin.